vs

Side-by-side financial comparison of Community Healthcare Trust Inc (CHCT) and DNA X, Inc. (SONM). Click either name above to swap in a different company.

Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $16.2M, roughly 1.9× DNA X, Inc.). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -29.3%, a 37.4% gap on every dollar of revenue. On growth, DNA X, Inc. posted the faster year-over-year revenue change (7.9% vs 4.8%). Over the past eight quarters, DNA X, Inc.'s revenue compounded faster (9.9% CAGR vs 7.0%).

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

CHCT vs SONM — Head-to-Head

Bigger by revenue
CHCT
CHCT
1.9× larger
CHCT
$31.5M
$16.2M
SONM
Growing faster (revenue YoY)
SONM
SONM
+3.1% gap
SONM
7.9%
4.8%
CHCT
Higher net margin
CHCT
CHCT
37.4% more per $
CHCT
8.1%
-29.3%
SONM
Faster 2-yr revenue CAGR
SONM
SONM
Annualised
SONM
9.9%
7.0%
CHCT

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CHCT
CHCT
SONM
SONM
Revenue
$31.5M
$16.2M
Net Profit
$2.5M
$-4.8M
Gross Margin
11.2%
Operating Margin
-24.5%
Net Margin
8.1%
-29.3%
Revenue YoY
4.8%
7.9%
Net Profit YoY
60.2%
-89.2%
EPS (diluted)
$-4.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHCT
CHCT
SONM
SONM
Q1 26
$31.5M
Q4 25
$30.9M
Q3 25
$31.1M
$16.2M
Q2 25
$29.1M
$11.2M
Q1 25
$30.1M
$16.7M
Q4 24
$29.3M
$15.3M
Q3 24
$29.6M
$15.0M
Q2 24
$27.5M
$11.5M
Net Profit
CHCT
CHCT
SONM
SONM
Q1 26
$2.5M
Q4 25
$14.4M
Q3 25
$1.6M
$-4.8M
Q2 25
$-12.6M
$-7.5M
Q1 25
$1.6M
$458.0K
Q4 24
$1.8M
$-21.6M
Q3 24
$1.7M
$-2.5M
Q2 24
$-10.4M
$-6.6M
Gross Margin
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
Q3 25
11.2%
Q2 25
7.6%
Q1 25
50.0%
Q4 24
-1.2%
Q3 24
28.2%
Q2 24
25.8%
Operating Margin
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
Q3 25
-24.5%
Q2 25
-60.2%
Q1 25
3.9%
Q4 24
55.3%
Q3 24
-15.8%
Q2 24
-56.2%
Net Margin
CHCT
CHCT
SONM
SONM
Q1 26
8.1%
Q4 25
46.6%
Q3 25
5.3%
-29.3%
Q2 25
-43.2%
-66.8%
Q1 25
5.3%
2.7%
Q4 24
6.3%
-141.6%
Q3 24
5.9%
-16.7%
Q2 24
-37.9%
-57.5%
EPS (diluted)
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
$0.52
Q3 25
$0.03
$-4.83
Q2 25
$-0.50
$-0.79
Q1 25
$0.03
$0.08
Q4 24
$0.04
$-116.99
Q3 24
$0.04
$-9.32
Q2 24
$-0.42
$-1.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHCT
CHCT
SONM
SONM
Cash + ST InvestmentsLiquidity on hand
$2.6M
$2.1M
Total DebtLower is stronger
$5.1M
Stockholders' EquityBook value
$421.3M
$-701.0K
Total Assets
$1.0B
$40.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHCT
CHCT
SONM
SONM
Q1 26
$2.6M
Q4 25
$3.3M
Q3 25
$3.4M
$2.1M
Q2 25
$4.9M
$2.0M
Q1 25
$2.3M
$2.1M
Q4 24
$4.4M
$5.3M
Q3 24
$2.8M
$9.1M
Q2 24
$734.0K
$9.6M
Total Debt
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
$532.2M
Q3 25
$530.1M
$5.1M
Q2 25
$500.1M
$2.9M
Q1 25
$496.0M
$2.8M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Stockholders' Equity
CHCT
CHCT
SONM
SONM
Q1 26
$421.3M
Q4 25
$429.4M
Q3 25
$426.8M
$-701.0K
Q2 25
$437.8M
$-1.3M
Q1 25
$461.3M
$-1.1M
Q4 24
$476.0M
$-5.7M
Q3 24
$477.2M
$15.3M
Q2 24
$497.8M
$17.5M
Total Assets
CHCT
CHCT
SONM
SONM
Q1 26
$1.0B
Q4 25
$990.8M
Q3 25
$987.3M
$40.2M
Q2 25
$966.3M
$36.1M
Q1 25
$985.1M
$36.0M
Q4 24
$992.6M
$39.7M
Q3 24
$981.8M
$49.1M
Q2 24
$983.2M
$45.9M
Debt / Equity
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHCT
CHCT
SONM
SONM
Operating Cash FlowLast quarter
$-7.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
$56.4M
Q3 25
$12.7M
$-7.0M
Q2 25
$13.8M
$-4.9M
Q1 25
$14.4M
$-9.6M
Q4 24
$58.9M
$-4.5M
Q3 24
$13.8M
$-417.0K
Q2 24
$16.7M
$-3.4M
Free Cash Flow
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$9.6M
Q1 25
$9.7M
Q4 24
$34.2M
$-4.5M
Q3 24
$6.7M
$-554.0K
Q2 24
$9.5M
$-3.4M
FCF Margin
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
116.0%
Q3 25
24.6%
Q2 25
32.9%
Q1 25
32.3%
Q4 24
116.9%
-29.6%
Q3 24
22.5%
-3.7%
Q2 24
34.7%
-29.8%
Capex Intensity
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
66.3%
Q3 25
16.3%
Q2 25
14.5%
Q1 25
15.6%
Q4 24
84.1%
0.1%
Q3 24
24.2%
0.9%
Q2 24
26.1%
0.3%
Cash Conversion
CHCT
CHCT
SONM
SONM
Q1 26
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
-20.97×
Q4 24
32.14×
Q3 24
7.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons